Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,213,211 papers from all fields of science
Search
Sign In
Create Free Account
Serine/Threonine Kinase Inhibitor CBP501
A peptide with G2 checkpoint-abrogating activity. G2 checkpoint inhibitor CBP501 inhibits multiple serine/threonine kinases, including MAPKAP-K2, C…
Expand
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Activation of Nrf2 Pathways Correlates with Resistance of NSCLC Cell Lines to CBP501 In Vitro
N. Mine
,
Sayaka Yamamoto
,
D. Kufe
,
D. V. Von Hoff
,
T. Kawabe
Molecular Cancer Therapeutics
2014
Corpus ID: 4961006
CBP501 is an anticancer drug candidate that was investigated in two randomized phase II clinical trials for patients with…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required